Some biomarkers that can be used as markers of AKI condition include interleukin-18 (IL-18)5, neutrophil-gelatinase-associated lipocalin (NGAL)6–8, and myeloperoxidase (MPO)9. Here, LCN2 is linked to acute kidney injury.